There must be something about the human brain that’s different from the brains of other animals — something that enables humans to plan, imagine the future, solve crossword puzzles, tell sarcastic ...

Rashid, M. and Johnston-Wilder, S. (2025) Building Bridges, Not Barriers: A Brief Study of Developing Mathematical Resilience in FE GCSE Mathematics Resit Students. Creative Education, 16, 1637-1650.

Artificial intelligence (AI) is revolutionizing educational paradigms and transforming teaching practice thanks to machine learning, natural language processing and personalized tutoring systems. One ...

This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom vetoed a bill that would have tracked data centers’ growing water footprint in California. He ...

When a developer approached Saline Township, Michigan, with a proposal to turn 250 acres of farmland into a data center, the town board said no, citing opposition from residents. Then came the lawsuit ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...

Microsoft outlined steps for developers to migrate existing C++ projects to Visual Studio 2026 with updated toolsets, standards, and SDKs.

The Open VSX registry rotated access tokens after they were accidentally leaked by developers in public repositories and allowed threat actors to publish malicious extensions in an attempted ...

Merger creates $600-million-revenue data infrastructure company Fivetran CEO Fraser to lead combined company Deal highlights AI-driven data infrastructure demand Oct 13 (Reuters) - Data startups ...

Satellites beam data down to the Earth all around us, all the time. So you might expect that those space-based radio communications would be encrypted to prevent any snoop with a satellite dish from ...

AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...